Royal Bank of Canada’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2K | Sell |
2,441
-3,864
| -61% | -$3.17K | ﹤0.01% | 6441 |
|
|
2025
Q1 | $10K | Sell |
6,305
-20,606
| -77% | -$32.7K | ﹤0.01% | 5785 |
|
|
2024
Q4 | $82K | Buy |
26,911
+20,066
| +293% | +$61.1K | ﹤0.01% | 4988 |
|
|
2024
Q3 | $25K | Buy |
6,845
+945
| +16% | +$3.45K | ﹤0.01% | 5567 |
|
|
2024
Q2 | $24K | Buy |
5,900
+3,018
| +105% | +$12.3K | ﹤0.01% | 5613 |
|
|
2024
Q1 | $46K | Sell |
2,882
-14,645
| -84% | -$234K | ﹤0.01% | 5137 |
|
|
2023
Q4 | $266K | Buy |
17,527
+9,878
| +129% | +$150K | ﹤0.01% | 4336 |
|
|
2023
Q3 | $154K | Buy |
7,649
+4,353
| +132% | +$87.6K | ﹤0.01% | 4558 |
|
|
2023
Q2 | $93K | Buy |
3,296
+615
| +23% | +$17.4K | ﹤0.01% | 4960 |
|
|
2023
Q1 | $46K | Sell |
2,681
-5,249
| -66% | -$90.1K | ﹤0.01% | 5290 |
|
|
2022
Q4 | $161K | Buy |
7,930
+7,333
| +1,228% | +$149K | ﹤0.01% | 4609 |
|
|
2022
Q3 | $13K | Sell |
597
-13,956
| -96% | -$304K | ﹤0.01% | 5824 |
|
|
2022
Q2 | $409K | Sell |
14,553
-1,993
| -12% | -$56K | ﹤0.01% | 3827 |
|
|
2022
Q1 | $763K | Sell |
16,546
-6,347
| -28% | -$293K | ﹤0.01% | 3459 |
|
|
2021
Q4 | $1.92M | Buy |
22,893
+19,439
| +563% | +$1.63M | ﹤0.01% | 2754 |
|
|
2021
Q3 | $230K | Buy |
3,454
+1,178
| +52% | +$78.4K | ﹤0.01% | 4552 |
|
|
2021
Q2 | $121K | Sell |
2,276
-89
| -4% | -$4.73K | ﹤0.01% | 5002 |
|
|
2021
Q1 | $103K | Buy |
2,365
+1,697
| +254% | +$73.9K | ﹤0.01% | 4961 |
|
|
2020
Q4 | $35K | Buy |
668
+642
| +2,469% | +$33.6K | ﹤0.01% | 5262 |
|
|
2020
Q3 | $1K | Buy |
26
+4
| +18% | +$154 | ﹤0.01% | 5997 |
|
|
2020
Q2 | $1K | Buy |
+22
| New | +$1K | ﹤0.01% | 6015 |
|